Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-06-24
1994-10-11
Hook, Gregory
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514557, 514561, 514610, 514921, A61K 31415, A61K 3119, A61K 31195, A61K 3104
Patent
active
053547713
ABSTRACT:
Methods for treatment of free-radical-mediated tissue injury, particularly sepsis, are provided wherein compositions containing at least one keto analog of a branched-chain amino acid are administered. The composition is administered orally or parenterally, preferably in frequent or continuous dosages. Preferred forms of the keto analogs are their ornithine, arginine, or sodium salts.
REFERENCES:
Nachbauer et al., "Infusion of branched-chain-enriched amino solutions in sepsis", CA 100:61408u, 1984.
Andreoli et al., "Role of glutathione in protecting endothelial cells against hydrogen peroxide oxidant injury", J. Lab Clin. Med., 108(3):190-198, 1986.
Bower et al., Ann. Surg., 203:13-20 (1986).
Hasselgren et al., J. of Parenteral and Enteral Nutrition, 12:244-249 (1988).
U. Andrae et al., "Pyruvate and Related .alpha.-Ketoacids Protect Mammalian Cells in Culture Against Hydrogen Peroxide-Induced Cytotoxicity", Toxicology Letters, 28, pp. 93-98 (1985).
A. K. Salahudeen et al., "Hydrogen Peroxide-Induced Renal Injury--A Protective Role for Pyruvate in Vitro and In Vivo", J. Clin. Invest., 88, pp. 1886-1893, (1991).
L. Cavallini et al., "The Protective Action of Pyruvate on Recovery of Ischemic Rat Heart: Comparison with Other Oxidizable Substrates", J. Mol. Cell Cardiol., 22, pp. 143-154 (1990).
N. J. Benevenga et al., "Pyruvate Metabolism in the Dairy Calf", J. Dairy Sci., 47, pp. 1124-1126 (1965).
W. W. Shreeve et al., "Metabolism of [2.sup.-14 C] Pyruvate in Normal, Agromegalic and HGH-Treated Human Subjects", Acta Endo., 65, pp. 155-169 (1970).
A. K. Salahudeen et al., "Pyruvate (PYR) Protects Renal Tubular Epithelial Cells Against Hydrogen Peroxide (H.sub.2 O.sub.2) by Scavenging H.sub.2 O.sub.2 Through a Nonenzymatic Decarboxylation Reaction", J. Am. Soc. Nephrol., 1, p. 618 (1990).
K. A. Nath et al., "Pyruvate (PYR) Protects Against Hydrogen Peroxide (H.sub.2 O.sub.2)-Induced Renal Injury in Vitro and in Vivo", J. Am. Soc., Nephrol., 1, p. 637 (1991).
Hook Gregory
The Johns Hopkins University
LandOfFree
Methods for treatment of sepsis using branch chain amino acids does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treatment of sepsis using branch chain amino acids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treatment of sepsis using branch chain amino acids will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1658858